Doubling Down Following up on our recent white paper, Biopharma’s COVID Capital Comeback, here is a look at the greatest risk […]
Q3 2020 Report: Global Trends in Biopharma Transactions Each quarter our team at Locust Walk compiles key statistics and trends on strategic
Panel Recording! Knocking SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
CATEGORIES News Events Publications ARCHIVE Panel Recording: The Unexpected IPO Boom in Biopharma in Q2 Locust Walk partnered with Applied
The Unexpected IPO Boom for Biopharma in Q2 SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube Instagram CATEGORIES News Locust Walk
Global Trends in Biopharma Transactions Q2 2020 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members
Brave New World: Challenges from the East, Asia Biopharma, and Response to COVID-19 SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube
A Brave New World COVID-19 or SARS Cov-2 to be precise, has changed the world in many regards. From the
Deal Makers of Japan, Volume 2 We are pleased to present the second series of the Deal Makers of Japan